Informing Strategic Decision-Making in Pharma: What Role Does AI Play?
RESEARCH CONTENT:
Over several months and numerous conferences, Intelligencia AI polled PPM professionals across the U.S. and Europe to better understand challenges and opportunities related to data and artificial intelligence (AI).
Posted: 17 Oct 2024 | Published: 29 Aug 2024
|
|
Why We Need Artificial Intelligence to Predict the Probability of Success in Drug Development
WHITE PAPER:
When it comes to reducing risk and elevating decision-making in drug development, artificial intelligence (AI) is one of the tools to transform both.
Posted: 17 Oct 2024 | Published: 29 Aug 2024
|
|
Patented AI Platform Identifies Promising BioPharma Assets
BLOG:
Read how Intelligencia AI has taken a robust and scientifically sound approach to data and AI quality by prospectively validating algorithms through monitoring predictions of drug approval success over time. Prospective validation is the hard currency for AI.
Posted: 17 Oct 2024 | Published: 29 Aug 2024
|
|
Industry Trends and Assets to Watch Based on ASCO 2024
RESEARCH CONTENT:
The American Society of Clinical Oncology (ASCO) Annual Meeting ranks as one of the largest and most impactful oncology conferences. The content published during the annual meeting can change established practices, and many of the trends identified reflect the current or future industry landscape in oncology.
Posted: 17 Oct 2024 | Published: 29 Aug 2024
|
|
|
|
|
